Osaic Holdings
BCAX

Osaic Holdings’s Bicara Therapeutics BCAX Stock Holding History

Osaic Holdings’s Portfolio BCAX Stock Details BCAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$129K Sell
4,340
-149
-3% -$3.33K ﹤0.01% 4755
2026
Q1 		$89.3K Sell
4,489
-5
-0.1% -$86 ﹤0.01% 4767
2025
Q4 		$75.6K Buy
4,494
+87
+2% +$1.49K ﹤0.01% 4949
2025
Q3 		$69.6K Buy
4,407
+3,974
+918% +$44.5K ﹤0.01% 5085
2025
Q2 		$4.02K Buy
+433
New +$5.16K ﹤0.01% 6660
2025
Q1 		– Sell
-255
Closed -$4.44K – 7764
2024
Q4 		$4.44K Buy
255
+218
+589% +$4.54K ﹤0.01% 6261
2024
Q3 		$942 Buy
+37
New +$944 ﹤0.01% 6857

Other funds holding BCAX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
RTM
Red Tree Management Redwood City, California $147M AUM 202.18% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Osaic Holdings's BCAX Position: Q2 2026 in Review

Osaic Holdings reduced its Bicara Therapeutics (BCAX) stake by 3.3% in Q2 2026, selling an estimated $3.33K and leaving 4,340 shares worth $129K. The position accounts for ﹤0.01% of the portfolio, ranked #4755.

Osaic Holdings first reported a position in BCAX in Q3 2024 and has held it in 7 quarters since. 172 funds tracked by Wall St. Rank hold BCAX as of Q2 2026.

  • Osaic Holdings held 4,340 shares of Bicara Therapeutics worth $129K as of Q2 2026.
  • Osaic Holdings sold 149 Bicara Therapeutics shares in Q2 2026, an estimated $3.33K.
  • Bicara Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #4755 holding.
  • Osaic Holdings first reported a position in Bicara Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • 172 funds tracked by Wall St. Rank held Bicara Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.